IRIS
GABANO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.205
NA - Nord America 4.863
AS - Asia 3.033
SA - Sud America 540
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 13.764
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.713
RU - Federazione Russa 1.372
IE - Irlanda 1.084
SG - Singapore 881
CN - Cina 827
DE - Germania 698
SE - Svezia 550
HK - Hong Kong 449
VN - Vietnam 432
BR - Brasile 418
UA - Ucraina 418
IT - Italia 342
FI - Finlandia 261
FR - Francia 208
IN - India 156
GB - Regno Unito 116
CA - Canada 97
AR - Argentina 45
MX - Messico 40
IR - Iran 36
KR - Corea 36
PL - Polonia 35
ID - Indonesia 33
ZA - Sudafrica 33
BD - Bangladesh 32
BJ - Benin 30
TR - Turchia 28
JP - Giappone 27
BE - Belgio 23
ES - Italia 22
EC - Ecuador 19
IQ - Iraq 17
AT - Austria 15
LT - Lituania 15
PK - Pakistan 15
CL - Cile 14
CO - Colombia 14
NL - Olanda 14
EG - Egitto 12
UZ - Uzbekistan 11
PY - Paraguay 10
VE - Venezuela 10
MA - Marocco 9
TN - Tunisia 9
EU - Europa 8
RO - Romania 8
SA - Arabia Saudita 7
AL - Albania 6
PH - Filippine 6
JO - Giordania 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
HR - Croazia 4
IL - Israele 4
PA - Panama 4
PE - Perù 4
CH - Svizzera 3
ET - Etiopia 3
KE - Kenya 3
NG - Nigeria 3
TH - Thailandia 3
AU - Australia 2
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
OM - Oman 1
RE - Reunion 1
SN - Senegal 1
Totale 13.764
Salva come PNG Salva come JPEG
Città #
Dublin 1.076
Jacksonville 750
Hong Kong 446
Dearborn 412
Singapore 360
San Jose 353
Ashburn 326
Beijing 267
New York 225
Chandler 217
Wilmington 186
Moscow 164
Ho Chi Minh City 148
Ann Arbor 146
Los Angeles 142
Lauterbourg 141
Lawrence 134
Princeton 134
Piemonte 104
Hanoi 95
San Mateo 90
Andover 84
Munich 83
Buffalo 72
Toronto 55
São Paulo 53
Bremen 50
Grafing 49
Orem 46
Novara 40
Santa Clara 40
Seoul 34
Frankfurt am Main 33
Dallas 32
Redondo Beach 32
Cotonou 30
Helsinki 28
Denver 27
Tokyo 25
Chennai 24
Warsaw 24
Atlanta 22
Guangzhou 22
Haiphong 22
Montreal 22
Stockholm 22
Houston 21
Leawood 21
London 21
Nanjing 21
Brooklyn 20
Brussels 20
Hefei 20
Cave Creek 19
Mexico City 18
Monmouth Junction 18
Tianjin 18
Woodbridge 18
Zanjan 18
Chicago 16
Da Nang 16
Hangzhou 16
Johannesburg 16
Manchester 16
Boardman 15
Kunming 15
Norwalk 15
Poplar 15
Biên Hòa 14
Mumbai 14
Nuremberg 14
Rio de Janeiro 14
Augusta 11
Kocaeli 11
Seattle 11
Shanghai 11
Curitiba 10
Jinan 10
Phoenix 10
Tashkent 10
Turku 10
Ankara 9
Ardabil 9
Bexley 9
Boston 9
Fairfield 9
Hải Dương 9
Jakarta 9
Milan 9
Ninh Bình 9
Turin 9
Amsterdam 8
Hebei 8
Lahore 8
Quito 8
Rome 8
San Francisco 8
Vienna 8
Wroclaw 8
Belo Horizonte 7
Totale 7.591
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 160
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 154
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 149
195Pt NMR chemical shift: a chemometric approach 145
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 142
Transition metal carbonyl clusters in biology: A futile or niche research area? 142
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 140
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 135
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 134
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 133
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 133
A different way for the oxidation of the Pt(II) complexes 131
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 130
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 129
Different strategies to exploit Pt(IV) complexes as pro-drugs 128
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 128
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 127
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 127
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 126
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 123
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 123
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 122
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 122
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 121
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 121
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 120
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 120
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 120
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 119
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 119
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 117
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 117
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
A view on multi-action Pt(IV) antitumor prodrugs 116
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 115
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 115
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 113
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 111
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 110
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 110
HPLC method for the determination of monomer conversion and composition during the poly(styrene-r-methylmethacrylate) polymerization 110
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 108
Pt-195 NMR spectroscopy: A chemometric approach 107
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 106
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 106
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 105
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 105
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 104
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 104
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 100
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 99
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 99
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 99
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 99
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 99
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 98
Pt(IV) complexes as anticancer prodrugs 98
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 98
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 97
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 97
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 96
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 96
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 95
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 95
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 93
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 93
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 93
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 91
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 90
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 90
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 89
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 88
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 88
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 87
Experimental determination and modeling of the lipophilicity in platinum complexes 84
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 84
Targeting and delivery of Pt(II) antiproliferative drugs 81
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 81
Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex? 81
Ethynylestradiol-Pt(II) complexes for selective drug targeting 80
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 80
Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes 80
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 80
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 79
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities 79
The Relevance of Polar Surface Area (PSA) in Rationalizing Biological Properties of Several cis-Diamminemalonatoplatinum(II)-derivatives 78
Platinum Complexes With Substituted Phosphines: Synthesis, Characterization, And Antiproliferative Activity 77
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) 77
Nano-vectors for targeting and delivery of Pt-based anti-tumor drugs 76
Rhein to impart antimetastatic features to Pt(IV) complexes and to target brain 75
Ethynylestradiol Derivatives as Carrier for Selective Vehiculation of Cytotoxic Pt(II)-Malonate and Radioactive Tc Fragments Towards Cancer Cells 74
Biological Activity of Enantiomeric Complexes [PtCl2L2] (L2 = Aromatic Bisphosphanes and Aromatic Diamines) 74
Synthesis and characterization of a series of Pt(IV) complexes: relationship between cytotoxicity and physico-chemical parameters 74
Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes 74
Totale 10.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 46 140 17
2021/2022979 64 17 110 114 42 0 138 27 64 23 174 206
2022/20232.176 148 89 159 48 133 204 45 125 1.085 35 69 36
2023/2024676 48 59 57 11 103 0 130 8 9 4 146 101
2024/20251.397 16 49 88 25 70 94 158 82 312 156 73 274
2025/20265.518 338 276 470 941 553 420 793 1.006 426 295 0 0
Totale 13.944